Thromboinflammation in COVID-19: Unraveling the interplay of coagulation and inflammation

被引:5
|
作者
Obeagu, Emmanuel Ifeanyi [1 ]
Obeagu, Getrude Uzoma [2 ]
机构
[1] Kampala Int Univ, Dept Med Lab Sci, Kampala, Uganda
[2] Kampala Int Univ, Sch Nursing Sci, Kampala, Uganda
关键词
coagulation; COVID-19; inflammation; thrombin; THROMBOSIS; PLATELET; HEMOSTASIS; INHIBITION; ASPIRIN;
D O I
10.1097/MD.0000000000038922
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coronavirus disease 2019 (COVID-19) pandemic has not only challenged global health systems but also spurred intense scientific inquiry into its pathophysiology. Among the multifaceted aspects of the disease, coagulation abnormalities have emerged as a significant contributor to morbidity and mortality. From endothelial dysfunction to dysregulated immune responses, various factors contribute to the hypercoagulable state seen in severe COVID-19 cases. The dysregulation of coagulation in COVID-19 extends beyond traditional thromboembolic events, encompassing a spectrum of abnormalities ranging from microvascular thrombosis to disseminated intravascular coagulation (DIC). Endothelial injury induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection triggers a cascade of events involving platelet activation, coagulation factor consumption, and fibrinolysis impairment. Moreover, the virus direct effects on immune cells and the cytokine storm further exacerbate the prothrombotic milieu. Unraveling this intricate web of interactions between viral pathogenesis and host responses is essential for elucidating novel therapeutic targets and refining existing management strategies for COVID-19-associated coagulopathy. In the quest to unravel the complex interplay between coagulation and COVID-19, numerous clinical and laboratory studies have yielded invaluable insights into potential biomarkers, prognostic indicators, and therapeutic avenues. Anticoagulation therapy has emerged as a cornerstone in the management of severe COVID-19, although optimal dosing regimens and patient selection criteria remain subjects of ongoing investigation. Additionally, innovative approaches such as targeting specific components of the coagulation cascade or modulating endothelial function hold promise for future therapeutic development.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19
    Peerschke, Ellinor, I
    Valentino, Alisa
    So, Rachel J.
    Shulman, Scott
    Ravinder
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] Alterations in coagulation in COVID-19
    Carrillo-Esper, Raul
    Melgar Bieberach, Rebeca E.
    Jacinto-Flores, Sarahi A.
    Tapia-Salazar, Mauricio
    Campa-Mendoza, Angela N.
    CIRUGIA Y CIRUJANOS, 2020, 88 (06): : 787 - 793
  • [33] Immunity and Coagulation in COVID-19
    Avdonin, Piotr P.
    Blinova, Maria S.
    Serkova, Anastasia A.
    Komleva, Lidia A.
    Avdonin, Pavel V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [34] Coagulation disorder in COVID-19
    Kander, Thomas
    LANCET HAEMATOLOGY, 2020, 7 (09): : E630 - E632
  • [35] Coagulation and anticoagulation in COVID-19
    Hadid, Tarik
    Kafri, Zyad
    Al-Katib, Ayad
    BLOOD REVIEWS, 2021, 47
  • [36] Pneumomediastinum in COVID-19: Interplay Between Infection, Inflammation and Ventilation - a Case Series
    Srinivasan, A.
    Wilson, B.
    Krishnamani, P. K.
    Bear, M.
    Jayaram, T. H.
    Kesavan, R.
    Sarva, S.
    Patel, P. R.
    Alim, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [37] Unraveling the Relationship of Asthma and COVID-19
    Bakakos, Agamemnon
    Bakakos, Petros
    Rovina, Nikoletta
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [38] UNRAVELING THE MYSTERIES OF CHRONIC COVID-19
    Teo, Yi Xiang
    Siew, Michelle
    Abraham, George M.
    CRITICAL CARE MEDICINE, 2024, 52
  • [39] The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome
    Alessandro Mengozzi
    Georgios Georgiopoulos
    Marco Falcone
    Giusy Tiseo
    Nicola Riccardo Pugliese
    Meletios A. Dimopoulos
    Lorenzo Ghiadoni
    Greta Barbieri
    Francesco Forfori
    Laura Carrozzi
    Massimo Santini
    Fabio Monzani
    Salvatore De Marco
    Francesco Menichetti
    Agostino Virdis
    Stefano Masi
    Scientific Reports, 11
  • [40] The most important biomarker associated with coagulation and inflammation among COVID-19 patients
    Hong, Ling-Zhi
    Shou, Zhang-Xuan
    Zheng, De-Ming
    Jin, Xue
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (07) : 2877 - 2885